Javier Torres

Long‐term follow‐up of a randomized prospective trial comparing a standard 81 mg dose of intravesical bacille Calmette‐Guérin with a reduced dose of 27 mg in superficial bladder cancer

J.A. Martínez‐Pin ̃eiro, N Flores, Santiago Isorna et al. · British Journal of Urology · 2002 · 217 citations · Full text

Medicine, Oncology, Urology +7

Risk-Directed Ambulatory Thromboprophylaxis in Lung and Gastrointestinal Cancers

Marliese Alexander, Sam Harris, Craig Underhill et al. · JAMA Oncology · 2023 · 30 citations · Full text

Pharmacy, Oncology, Risk Management +17

Real‐world first‐line systemic therapy patterns in metastatic castration‐resistant prostate cancer

A. Antón, Sruti Pillai, Marie C. Semira et al. · BJUI Compass · 2021 · 19 citations · Full text

Medicine, Oncology, Pharmacotherapy +17

Treatment patterns and outcomes in older adults with castration-resistant prostate cancer: Analysis of an Australian real-world cohort

Michael Fernando, A. Antón, Andrew Weickhardt et al. · Journal of Geriatric Oncology · 2023 · 16 citations

Medicine, Oncology, Urology +13

M-CAVI, A Neoadjuvant Carboplatin-based Regimen for the Treatment of T2-4N0M0 Carcinoma of the Bladder

Joaquim Bellmunt, Antoni Ribas, Joan Albanell et al. · American Journal of Clinical Oncology · 1996 · 13 citations

Medicine, Oncology, Urology +14